Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade GliomasJacquelyn M. Dougherty(Children's Hospital of Philadelphia), Thomas De Raedt(KU Leuven)PLoS ONEFebruary 2, 202310.1371/journal.pone.0277305Cited by 4SaveCiteExport RISWatch citationsRelated PapersIntestinal Neurofibromatosis Is a Subtype of Familial GIST and Results From a Dominant Activating Mutation in PDGFRA|Gastroenterology|2006|73